TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $74,208 | -51.2% | 74,297 | -11.8% | 0.00% | – |
| Q3 2022 | $152,000 | -39.0% | 84,242 | -1.8% | 0.00% | – |
| Q2 2022 | $249,000 | +37.6% | 85,827 | +1.2% | 0.00% | – |
| Q1 2022 | $181,000 | -53.9% | 84,792 | +0.5% | 0.00% | – |
| Q4 2021 | $393,000 | -52.6% | 84,407 | -13.4% | 0.00% | -100.0% |
| Q3 2021 | $829,000 | -63.9% | 97,413 | -30.3% | 0.00% | -50.0% |
| Q2 2021 | $2,294,000 | -91.6% | 139,740 | -88.7% | 0.00% | -92.9% |
| Q1 2021 | $27,189,000 | +320.6% | 1,231,400 | +489.1% | 0.03% | +300.0% |
| Q4 2020 | $6,465,000 | +131.0% | 209,016 | +51.7% | 0.01% | +75.0% |
| Q3 2020 | $2,799,000 | +118.2% | 137,765 | +65.0% | 0.00% | +100.0% |
| Q2 2020 | $1,283,000 | -1.6% | 83,499 | -50.4% | 0.00% | +100.0% |
| Q1 2020 | $1,304,000 | +5.7% | 168,482 | +94.9% | 0.00% | 0.0% |
| Q4 2019 | $1,234,000 | +539.4% | 86,432 | +572.4% | 0.00% | – |
| Q3 2019 | $193,000 | +22.9% | 12,854 | +16.9% | 0.00% | – |
| Q2 2019 | $157,000 | -18.2% | 11,000 | 0.0% | 0.00% | – |
| Q1 2019 | $192,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |